Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers

Completed

Conditions studied: Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations

In brief

The purpose of this screening study is to identify people who have a rare genetic cause of obesity - specifically three genetic variants (a change in the DNA structure) of the POMC, PCSK1 and LepR genes that are currently known to result in obesity. This screening study will not include any investigational drugs. You will be asked to provide a DNA sample and answer some questions about your medical history and hunger.

Key facts

Study ID
NCT02849977
Run by
Rhythm Pharmaceuticals, Inc.
People needed
5966
Starts
2016-09-28
Expected to finish
2020-06-09
Last updated by the study team
2022-11-15

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.